ClinicalTrials.gg
RecruitingNCT06305091Updated Mar 12, 2024

DNA Methylation Markers in Veterans Exposed to Open Burn Pits

An observational study in Open Burn Pit Exposure, sponsored by Central Arkansas Veterans Healthcare System. Recruiting at 1 site in United States. Open to participants aged 25 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-12.

Sponsored by Central Arkansas Veterans Healthcare System · Observational

How we know

From the registry’s dates

  • Started Mar 2023; still recruiting 3 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
330
Ages
25 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 336 studies in Burns with a site in United States — 40 open to participants now, 51 under way, 5 of them phase 3. Burns · United States.

Planned enrollment
13th of 61
330 · median 59
Started
2023
with 12 others
Observational
61 of 336
9 open now
Primary completion
2027-03
later than 24 of 50 live
Registered
302nd of 336
by date

Among the 336 studies in Burns with a site in United States, this one is the 13th largest by planned enrollment of the 61 observational ones that give a count, is one of 13 that started in 2023, is one of 61 observational ones, reaches primary completion later than 24 of the 50 other live ones, and was the 302nd registered.

Burns

906 studies on the registry are indexed under Burns; 165 are open to participants now.

Browse Burns studies →

Open to participants now

40 of the 336 studies in Burns with a site in United States are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 87 Burns studies recruiting now, 38 (44%) set no upper age limit and 38 (44%) stop at 75 or younger; 17 take children under 18; 10 take healthy volunteers.

This study: 25 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 336 studies in Burns with a site in United States, or all of them as a file.
02

Study summary

Background: The VA and DoD estimate that 3.5 million Veterans and Service Members were exposed to open burn pits used for waste disposal during military deployments to countries such as Kuwait, Afghanistan, and Iraq since 1990. Since the lasting adverse effects of this exposure on health are unknown, the VA Airborne Hazards and Open Burn Pit Registry (AHOBPR) was created. More than 209,000 participants to date have answered the registry questionnaire about the extent of exposure to burn pits and other airborne hazards. The questions attempted to quantify the duration of exposure, the severity of acute health effects, and the relative timing of onset or worsening of chronic respiratory, cardiovascular, neurological, and other illnesses. However, the AHOBPR interview lacks specific inquiry about mental health and biomarkers. The proposed study will recruit AHOBPR participants and non-participant for a follow-up enhanced evaluation of their health in a translational research study to better characterize their psychological, physical health profile, and potentially harmful epigenetic and biochemical exposure-related alterations.

Hypothesis: The investigators hypothesize that 1) the severity of individual exposure to burn pits will be positively correlated with levels of persistent organic pollutants in blood and metals in urine and specific epigenetic alterations in DNA methylation; and 2) levels of toxic chemicals and alterations in the methylation of specific genes will be positively correlated with chronic problems involving the cardiovascular, respiratory, neuropsychiatric and other systems.

Specific Aims: (1) Describe and quantify relationships of the intensity and duration of exposure with persistent organic chemicals/metals in the registry participants and ascertain their relationships with health outcomes linked to burn pit exposure. (2) Discover and validate DNA methylation marks that best distinguish between individuals exposed to burn pits and those not; then describe and quantify the relationships between DNA methylation, intensity and duration of exposure, and health outcomes. Completion of these aims will allow quantitation of the relationships between toxic chemicals, DNA methylation, and individual health problems.

Study Design: A clinical study will be conducted at the Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences. The AHOBPR registry and non-specific recruitment will be used to enroll OBP exposed (N=220) and age and gender-matched unexposed (N=110) veterans. The unexposed veterans will be given the same questions as in the AHOBPR to determine their open burn pit exposure status with a confirmation of no exposure. A single study visit per participant will strengthen the registry by validating its contents using the electronic patient record and adding new study data on physical and mental function, including effects of epigenetic and toxicant measures obtained from blood and urine samples. Linear and logistic regression modeling will be used to determine the relationships described by the study aims while controlling for confounding variables and false discovery rates.

Long-term and Short-term Impact on Patient Populations: The immediate goal of the study is to measure exposure-related differences in levels of potentially toxic chemicals present in blood and urine and differences in DNA methylation. The study will then determine the relationships between exposure, the biochemical and molecular measures, and the presence of health problems. The value of this information is high since the effects of burn pit exposure are largely unknown but potentially serious. The longer-term goal for this line of investigation is to enable personalized and tailored health management for exposed individuals. The investigators believe that the biochemical and molecular measures may become novel biomarkers that enable the prediction of risk for disease and adverse disease outcomes such that preventative measures can be employed. Furthermore, the results will be highly relevant to other occupations in which exposure to airborne pollutants is high.

03

Conditions studied

  • Open Burn Pit Exposure

Browse trials for

Keywords

  • Open Burn Pits
  • toxic exposure
  • veterans
04

Who can participate

Ages eligible
25 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Veterans aged 25- 70 years

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 25-70 years
  • Participants that reside in Arkansas
  • All Veterans that are deployed
  • Participants registered in the AHOBPR burn pit registry mainly for exposed Veterans. However, unexposed participants from the registry could also be included.
  • Participants not listed in the AHOBPR burn pit registry mainly for unexposed Veterans. However, exposed participants not from the registry could also be included.
  • Non-smokers: defined as smoke less than 10 cigarettes during lifetime.
  • Fluent in English

Exclusion criteria

Exclusion Criteria:

  • Any occupation and/or hobbies involves diesel exhaust, welding, paint, or other chemical fumes or organic dust
  • Any use of tobacco or nicotine products within the past year, such as smoking (cigarettes, pipes, cigars, e-cigarettes, vaping devices)
  • Self-report and/or chart review that patient is pregnant
  • Self-report and/or chart review that patient weight is less than 110 lbs
  • Participants whom the PI deems to be otherwise ineligible
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
330 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • OBP exposed

    Veterans exposed to Open Burn Pits (N=220)

    Diagnostic Test: Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples

  • OBP not exposed

    Veterans not exposed to Open Burn Pits (N=110)

    Diagnostic Test: Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples

Interventions

  • Diagnostic testHealth survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples

    Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples

06

What researchers measure

Primary outcomes

  1. DNA methylation markers and heavy metals

    Time frame: Day 1

Secondary outcomes

  1. Physical and mental health comorbidities

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
  • Central Arkansas Veterans Healthcare System (3J/NLR)
    North Little Rock, Arkansas 72114, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2023 (actual). Primary completion is estimated for Mar 2027, 48 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2024
First posted
Mar 12, 2024
StartActual
Mar 13, 2023
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Mar 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06305091
Lead sponsor
Central Arkansas Veterans Healthcare System
Collaborators
United States Department of Defense, University of Arkansas
Responsible party
Kalpana Padala, MD (Associate Director Research, GRECC, Central Arkansas Veterans Healthcare System) — Principal investigator
First posted
Mar 12, 2024
Start date
Mar 13, 2023
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Mar 12, 2024

Study contacts

Kalpana Padala, MD, MS
Contact
kalpana.padala@va.gov
501-257-2044
Trent Trice, BS
Contact
trent.trice@va.gov
501-257-2403
Kalpana Padala, MD, MS
principal investigator · Central Arkansas Veterans Healthcare System, Little Rock, AR
Shuk-Mei Ho, PhD
principal investigator · University of Arkansas for Medical Sciences, Little Rock, AR

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion